Earnings Preview For Biolase
Portfolio Pulse from Benzinga Insights
Biolase (NASDAQ:BIOL) is scheduled to release its quarterly earnings report on March 21, 2024, with an estimated EPS of $-2.55. The company's past earnings performance shows a pattern of not meeting EPS estimates, leading to significant share price drops the following day. Shares are currently trading at $0.14, reflecting a 99.59% decrease over the last 52 weeks. Investors are looking for positive guidance for the next quarter.
March 20, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biolase is expected to report an EPS of $-2.55 for the upcoming earnings, with a history of not meeting EPS estimates and subsequent share price declines.
Given Biolase's history of not meeting EPS estimates and the significant negative impact on its share price following earnings reports, it is likely that the upcoming earnings announcement could lead to a further decrease in share price, especially if the company fails to meet or exceed the estimated EPS again. The stock's current low price and the 99.59% decrease over the last year further contribute to the negative outlook.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100